TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cardiocomm Solutions ( (TSE:EKG) ) has provided an announcement.
CardioComm Solutions has secured a royalty-based financing deal to support the commercial launch of its new flagship 14-day Holter-Event GEMS software platform. This financial arrangement will enable the company to finalize, market, and support its principal offering, which is expected to become a major revenue source. The deal involves converting existing debt into a royalty agreement, aligning the interests of lenders with the company’s success and providing new capital to enhance product development and market penetration.
More about Cardiocomm Solutions
CardioComm Solutions, Inc. is a global provider in the medical industry, specializing in consumer heart monitoring and electrocardiogram (ECG) software solutions. The company focuses on delivering advanced remote monitoring capabilities for healthcare professionals and patients.
Average Trading Volume: 67,262
Technical Sentiment Signal: Sell
Current Market Cap: C$1.93M
For a thorough assessment of EKG stock, go to TipRanks’ Stock Analysis page.